[1] Deisseroth K, Feng G, Majewska A K, et al. Next-generation optical technologies for illuminating genetically targeted brain circuits[J]. Journal of Neuroscience, 2006, 26(41):10380-10386.
[2] Miesenböck G. The optogenetic catechism[J]. Science, 2009, 326(5951):395-399.
[3] Zemelman B V, Lee G A, Ng M, et al. Selective photostimulation of genetically chARGed neurons[J]. Neuron, 2002, 33(1):15-22.
[4] Miesenböck G. Lighting up the brain[J]. Scientifc American, 2008, 299(4):52-59.
[5] Miesenböck G, Kevrekidis I G. Optical imaging and control of genetically designated neurons in functioning circuits[J]. Annual Review of Neurosci, 2005, 28:533-563.
[6] Lima S Q, Miesenböck G. Remote control of behavior through genetically targeted photostimulation of neurons[J]. Cell, 2005, 121(1):141-152.
[7] Banghart M, Borges K, Isacoff E, et al. Light-activated ion channels for remote control of neuronal firing[J]. Nature Neuroscience, 2004, 7(12):1381-1386.
[8] Nagel G, Ollig D, Fuhrmann M, et al. Channelrhodopsin-1:A light-gated proton channel in green algae[J]. Science, 2002, 296(5577):2395-2398.
[9] Nagel G, Szellas T, Huhn W, et al. Channelrhodopsin-2, a directly light-gated cation-selective membrane channel[J]. PNAS, 2003, 100(24):13940-13945.
[10] Lin J Y, Knutsen P M, Muller A, et al. ReaChR:A red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation[J]. Nature Neuroscience, 2013, 16(10):1499-1508.
[11] Boyden E S, Zhang F, Bamberg E, et al. Millisecond-timescale, genetically targeted optical control of neural activity[J]. Nature Neuroscience, 2005, 8(9):1263-1268.
[12] Li X, Gutierrez D V, Hanson M G, et al. Fast noninvasive activation and inhibition of neural and network activity by vertebrate rhodopsin and green algae channelrhodopsin[J]. PNAS, 2005, 102(49):17816-17821.
[13] Ishizuka T, Kakuda M, Araki R, et al. Kinetic evaluation of photosensitivity in genetically engineered neurons expressing green algae light-gated channels[J]. Neuroscience Research, 2006, 54(2):85-94.
[14] Bi A, Cui J, Ma Y P, et al. Ectopic expression of a microbialtype rhodopsin restores visual responses in mice with photoreceptor degeneration[J]. Neuron, 2006, 50(1):23-33.
[15] Miesenbock G. Optogenetic control of cells and circuits[J]. Annual Review of Cell and Developmental Biology, 2011, 27:731-758.
[16] Iseki M, Matsunaga S, Murakami A, et al. A blue-light-activated adenylyl cyclase mediates photoavoidance in Euglena gracilis[J]. Nature, 2002, 415(6875):1047-1051.
[17] Volgraf M, Gorostiza P, Numano R, et al. Allosteric control of an ionotropic glutamate receptor with an optical switch[J]. Nature Chemical Biology, 2006, 2(1):47-52.
[18] Kennedy M J, Hughes R M, Peteya L A, et al. Rapid bluelight-mediated induction of protein interactions in living cells[J]. Nature Methods, 2010, 7(12):973-975.
[19] Vitaterna M H, Selby C P, Todo T, et al. Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2[J]. PNAS, 1999, 96(21):12114-12119.
[20] Shimizu-Sato S, Huq E, Tepperman J M, et al. A light-switchable gene promoter system[J]. Nature Biotechnology, 2002, 20(10):1041-1044.
[21] Polosukhina A, Litt J, Tochitsky I, et al. Photochemical restoration of visual responses in blind mice[J]. Neuron, 2012, 75(2):271-282.
[22] Tochitsky I, Polosukhina A, Degtyar V E, et al. Restoring visual function to blind mice with a photoswitch that exploits electrophysiological remodeling of retinal ganglion cells[J]. Neuron, 2014, 81(4):800-813.
[23] Feldbauer K, Zimmermann D, Pintschovius V, et al. Channelrhodopsin-2 is a leaky proton pump[J]. PNAS, 2009, 106(30):12317-12322.
[24] Lin J Y. A user's guide to channelrhodopsin variants:Features, limitations and future developments[J]. Experimental Physiology, 2011, 96(1):19-25.
[25] Bamann C, Kirsch T, Nagel G, et al. Spectral characteristics of the photocycle of channelrhodopsin-2 and its implication for channel function[J]. Journal of Molecular Biology, 2008, 375(3):686-694.
[26] Lin J Y, Lin M Z, Steinbach P, et al. Characterization of engineered channelrhodopsin variants with improved properties and kinetics[J]. Biophysical Journal, 2009, 96(5):1803-1814.
[27] Pan Z H, Ganjawala T H, Lu Q, et al. ChR2 mutants at L132 and T159 with improved operational light sensitivity for vision restoration[J]. PLoS One, 2014, 9(6):e98924.
[28] Nagel G, Szellas T, Kateriya S, et al. Channelrhodopsins:Directly light-gated cation channelsv. Biochemical Society Transactions, 2005, 33(4):863-866.
[29] Wen L, Wang H, Tanimoto S, et al. Opto-current-clamp actuation of cortical neurons using a strategically designed channelrhodopsin[J]. PLoS One, 2010, 5(9):e12893.
[30] Berndt A, Yizhar O, Gunaydin L A, et al. Bi-stable neural state switches[J]. Nature Neuroscience, 2009, 12(2):229-234.
[31] Kleinlogel S, Feldbauer K, Dempski R E, et al. Ultra lightsensitive and fast neuronal activation with the Ca2+-permeable channelrhodopsin CatCh[J]. Nature Neuroscience, 2011, 14(4):513-518.
[32] Chuong A S, Miri M L, Busskamp V, et al. Noninvasive optical inhibition with a red-shifted microbial rhodopsin[J]. Nature Neuroscience, 2014, 17(8):1123-1129.
[33] Berthold P, Tsunoda S P, Ernst O P, et al. Channelrhodopsin-1 initiates phototaxis and photophobic responses in chlamydomonas by immediate light-induced depolarization[J]. Plant Cell, 2008, 20(6):1665-1677.
[34] Zhang F, Prigge M, Beyriere F, et al. Red-shifted optogenetic excitation:A tool for fast neural control derived from Volvox carteri[J]. Nature Neuroscience, 2008, 11(6):631-633.
[35] Tsunoda S P, Hegemann P. Glu 87 of channelrhodopsin-1 causes pH-dependent color tuning and fast photocurrent inactivation[J]. Photochem Photobiol, 2009, 85(2):564-569.
[36] Berndt A, Lee S Y, Ramakrishnan C, et al. Structure-guided transformation of channelrhodopsin into a light-activated chloride channel[J]. Science, 2014, 344(6182):420-424.
[37] Wietek J, Wiegert J S, Adeishvili N, et al. Conversion of channelrhodopsin into a light-gated chloride channel[J]. Science, 2014, 344(6182):409-412.
[38] Prigge M, Schneider F, Tsunoda S P, et al. Color-tuned channelrhodopsins for multiwavelength optogenetics[J]. Journal of Biological Chemistry, 2012, 287(38):31804-31812.
[39] Tomita H, Sugano E, Murayama N, et al. Restoration of the majority of the visual spectrum by using modified Volvox channelrhodopsin-1[J]. Molecular Therapy, 2014, 22(8):1434-1440.
[40] Govorunova E G, Sineshchekov O A, Li H, et al. Characterization of a highly efficient blue-shifted channelrhodopsin from the marine alga Platymonas subcordiformis[J]. Journal of Biological Chemistry, 2013, 288(41):29911-29922.
[41] Klapoetke N C, Murata Y, Kim S S, et al. Independent optical excitation of distinct neural populations[J]. Nature Methods, 2014, 11(3):338-346.
[42] Govorunova E G, Sineshchekov O A, Janz R, et al. Natural light-gated anion channels:A family of microbial rhodopsins for advanced optogenetics[J]. Science, 2015, 349(6248):647-650.
[43] Surace E M, Auricchio A. Versatility of AAV vectors for retinal gene transfer[J]. Vision Research, 2008, 48(3):353-359.
[44] Kay C N, Ryals R C, Aslanidi G V, et al. Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors[J]. PLoS One, 2013, 8(4):e62097.
[45] Petrs-Silva H, Dinculescu A, Li Q, et al. High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors[J]. Molecular Therapy, 2009, 17(3):463-471.
[46] Daya S, Berns K I. Gene therapy using adeno-associated virus vectors[J]. Clinical Microbiology Reviews, 2008, 21(4):583-593.
[47] Gray S J, Blake B L, Criswell H E, et al. Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB)[J]. Molecular Therapy, 2010, 18(3):570-578.
[48] Cronin T, Vandenberghe L H, Hantz P, et al. Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter[J]. EMBO Molecular Medicine, 2014, 6(9):1175-1190.
[49] Lu Q, Ganjawala T H, Ivanova E, et al. AAV-mediated transduction and targeting of retinal bipolar cells with improved mGluR6 promoters in rodents and primates[J]. Gene Therapy, 2016, 23(8/9):680-689.
[50] Macé E, Caplette R, Marre O, et al. Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV restores On and Off visual responses in blind mice[J]. Molecular Therapy, 2015, 23(1):7-16.
[51] Adamantidis A R, Zhang F, Aravanis A M, et al. Neural substrates of awakening probed with optogenetic control of hypocretin neurons[J]. Nature, 2007, 450(7168):420-424.
[52] Carter M E, Yizhar O, Chikahisa S, et al. Tuning arousal with optogenetic modulation of locus coeruleus neurons[J]. Nature Neuroscience, 2010, 13(12):1526-1533.
[53] Rolls A, Colas D, Adamantidis A, et al. Optogenetic disruption of sleep continuity impairs memory consolidation[J]. PNAS, 2011, 108(32):13305-13310.
[54] Liu X, Ramirez S, Pang P T, et al. Optogenetic stimulation of a hippocampal engram activates fear memory recall[J]. Nature, 2012, 484(7394):381-385.
[55] Hegemann P. Algal sensory photoreceptors[J]. Annual Review of Plant Biology, 2008, 59:167-189.
[56] Ivanova E, Hwang G S, Pan Z H, et al. Evaluation of AAVmediated expression of Chop2-GFP in the marmoset retina[J]. Investigative Ophthalmology & Visual Sciene, 2010, 51(10):5288-5296.
[57] Boye S E, Boye S L, Lewin A S, et al. A comprehensive review of retinal gene therapy[J]. Molecular Therapy, 2013, 21(3):509-519.
[58] Iyer S M, Montgomery K L, Towne C, et al. Virally mediated optogenetic excitation and inhibition of pain in freely moving nontransgenic mice[J]. Nature Biotechnology, 2014, 32(3):274-278.
[59] Vogt C C, Bruegmann T, Malan D, et al. Systemic gene transfer enables optogenetic pacing of mouse hearts[J]. Cardiovascular Research, 2015, 106(2):338-343.
[60] Parker K L, Kim Y, Alberico S L, et al. Optogenetic approaches to evaluate striatal function in animal models of Parkinson disease[J]. Dialogues in Clinical Neuroscience, 2016, 18(1):99-107.
[61] Kravitz A V, Freeze B S, Parker P R, et al. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry[J]. Nature, 2010, 466(7306):622-626.
[62] Ingles-Prieto A, Reichhart E, Schelch K, et al. The optogenetic promise for oncology:Episode I[J]. Molecular & Cellular Oncology, 2014, 1(4):e964045.
